Professor, Departments of Medicine and Biochemistry & Molecular Biology
Director, Libin Gene Therapy Unit Member
Kumar’s expertise is in chromosome biology, functional genomics, and bioinformatics. He currently oversees the development of the MRS and PATRN platforms.
Prior to cBio, Kumar held business development and program management roles at Ibis Biosciences and Abbott, where his work led directly to the spin-off of cBio. Kumar has been a director of program management efforts at the California Institute of Regenerative Medicine and at the Myelin Repair Foundation, where he continues to volunteer.